Healthy Clinical Trial
Official title:
Effects of Sauna Bathing on Sleep, Mood and Stress
NCT number | NCT06125639 |
Other study ID # | AWF_SKN_1 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | October 20, 2023 |
Est. completion date | May 2024 |
Verified date | November 2023 |
Source | University School of Physical Education, Krakow, Poland |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Sauna bathing is a popular, low-cost, and easily accessible type of whole-body thermotherapy that has been used for social, religious, health, and hygienic reasons for thousands of years. There is strong evidence to support the various physiological and psychological benefits of sauna bathing. The positive effects of regular sauna use have been explained by a number of mechanisms of action, including increased cardiac output, reduced peripheral vascular resistance and other physiological changes in cardiovascular parameters such as decreased systolic and/or diastolic blood pressure. Additionally, the psychological impact of sauna bathing may occur due to a combination of factors that include the release of endorphins, relaxation, placebo effects, and psychological and social interactions that likely occur around frequent sauna activity. Taken together, it is possible that acute and regular sauna bathing may impact sleep quality.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | May 2024 |
Est. primary completion date | May 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - good general health assessed by physician - written consent to participate Exclusion Criteria: - medication or dietary supplements, which could potentially impact the study outcomes - history of sleep or neurological disorders - regular sauna use - professional athlete - shift worker |
Country | Name | City | State |
---|---|---|---|
Poland | University School of Physical Education in Cracow | Kraków | |
Poland | University School of Physical Education in Cracow | Kraków |
Lead Sponsor | Collaborator |
---|---|
University School of Physical Education, Krakow, Poland | University of Bergen |
Poland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Objective Sleep - Time in bed | Total time spent in bed during the night assessed by sleep radar | 5 weeks | |
Primary | Objective Sleep - Sleep-onset latency | The time it takes from when the participant intends to go to sleep and actually starts to sleep assessed by sleep radar | 5 weeks | |
Primary | Objective Sleep - Total sleep time | Total sleep time obtained from sleep onset to time at wake-up assessed by sleep radar | 5 weeks | |
Primary | Objective Sleep - Light sleep | Total amount of time in light sleep assessed by sleep radar | 5 weeks | |
Primary | Objective Sleep - Deep sleep | Total amount of time in deep sleep assessed by sleep radar | 5 weeks | |
Primary | Objective Sleep - REM sleep | Total amount of time in REM sleep assessed by sleep radar | 5 weeks | |
Primary | Objective Sleep - Sleep efficiency | The percentage of total sleep time to lights off and leaving bed assessed by sleep radar | 5 weeks | |
Secondary | Subjective Sleep Quality assessed by Karolinska Sleep Diary | 5 weeks | ||
Secondary | Stress level assessed by VAS scale | VAS scale is a 11-item self-report measure for stress. Answers range from 0 (no stress) to 10 (worst stress). | 5 weeks | |
Secondary | Positive and Negative Affect Schedule (PANAS) | The PANAS is a 20-item self-report measure for positive and negative affect. | baseline, after 1,3,6,9 sauna bathing, after 5 weeks | |
Secondary | Mood | Mood Adjective Check List (UMACL) will be used to assess mood (Mathews, Chamberlain & Jones, 1990, adapted to Polish by Ewa Gorynska, 2005). UMACL measures mood in three dimensions of the core affect: Tense Arousal (minimum value: 9, maximum value: 36), Energetic Arousal (minimum value: 10, maximum value: 40), and Hedonic Tone (minimum value: 10, maximum value: 40), with higher scores representing higher levels of the mood dimensions. | baseline, after 1,3,6,9 sauna bathing, after 5 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |